$CBUS
Cibus, Inc.

2022 Q1 Form 10-K Financial Statement

#000095017022002808 Filed on March 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021
Revenue $32.00K $1.943M $25.99M
YoY Change -99.27% -86.05% 8.96%
Cost Of Revenue $0.00 $2.004M $28.56M
YoY Change -100.0% -89.37% -18.7%
Gross Profit $32.00K -$61.00K -$2.570M
YoY Change -101.37% -98.77% -77.21%
Gross Profit Margin 100.0% -3.14% -9.89%
Selling, General & Admin $3.180M $3.787M $15.43M
YoY Change -25.87% -16.59% -57.96%
% of Gross Profit 9937.5%
Research & Development $2.941M $2.862M $11.34M
YoY Change -3.57% -12.48% 2.28%
% of Gross Profit 9190.63%
Depreciation & Amortization $370.0K $562.0K $2.338M
YoY Change -36.75% 12.4% 25.09%
% of Gross Profit 1156.25%
Operating Expenses $6.121M $6.649M $26.76M
YoY Change -16.58% -14.76% -17.8%
Operating Profit -$6.089M -$6.710M -$29.33M
YoY Change -37.1% -47.33% -33.08%
Interest Expense $470.0K -$347.0K $1.431M
YoY Change 30.56% -15.37% -0.28%
% of Operating Profit
Other Income/Expense, Net $487.0K $19.00K
YoY Change -48800.0% -115.08%
Pretax Income -$5.619M -$7.057M -$29.20M
YoY Change -43.97% -47.34% -34.88%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.619M -$7.057M -$29.20M
YoY Change -43.97% -47.34% -34.87%
Net Earnings / Revenue -17559.38% -363.2% -112.36%
Basic Earnings Per Share -$1.34 -$0.78
Diluted Earnings Per Share -$133.7K -$184.3K -$779.1K
COMMON SHARES
Basic Shares Outstanding 42.72M 38.51M 37.48M
Diluted Shares Outstanding 4.202M 37.48M

Balance Sheet

Concept 2022 Q1 2021 Q4 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.29M $13.82M $13.82M
YoY Change -10.9% -52.33% -52.33%
Cash & Equivalents $17.29M $13.82M $13.82M
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $1.688M $1.358M $1.358M
YoY Change -54.38% -68.42% -68.42%
Inventory $0.00 $0.00
Prepaid Expenses $859.0K
Receivables $0.00 $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $18.97M $15.18M $15.18M
YoY Change -34.8% -61.65% -61.66%
LONG-TERM ASSETS
Property, Plant & Equipment $19.10M $21.73M $21.73M
YoY Change -15.12% -4.94% -5.1%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $274.0K $183.0K $282.0K
YoY Change -65.75% -34.64% -68.67%
Total Long-Term Assets $19.37M $22.01M $22.01M
YoY Change -16.86% -7.26% -7.12%
TOTAL ASSETS
Total Short-Term Assets $18.97M $15.18M $15.18M
Total Long-Term Assets $19.37M $22.01M $22.01M
Total Assets $38.35M $37.19M $37.19M
YoY Change -26.82% -41.27% -41.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.167M $1.260M $1.260M
YoY Change 16.7% 35.63% 40.0%
Accrued Expenses $2.588M $339.0K $2.861M
YoY Change -46.08% -88.27% -40.4%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $290.0K $370.0K $370.0K
YoY Change -27.5% -7.5% -7.5%
Total Short-Term Liabilities $9.520M $4.854M $4.854M
YoY Change 51.11% -30.11% -29.65%
LONG-TERM LIABILITIES
Long-Term Debt $89.00K $0.00 $17.51M
YoY Change -99.54% -100.0% -9.76%
Other Long-Term Liabilities $13.82M $702.0K $702.0K
YoY Change 1051.25% 521.24% 602.0%
Total Long-Term Liabilities $13.90M $702.0K $18.21M
YoY Change -32.18% -56.96% -6.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.520M $4.854M $4.854M
Total Long-Term Liabilities $13.90M $702.0K $18.21M
Total Liabilities $23.42M $23.06M $23.06M
YoY Change -12.6% -12.82% -12.97%
SHAREHOLDERS EQUITY
Retained Earnings -$196.1M
YoY Change 17.5%
Common Stock $211.3M
YoY Change 3.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.92M $14.13M $14.13M
YoY Change
Total Liabilities & Shareholders Equity $38.35M $37.19M $37.19M
YoY Change -26.82% -41.27% -41.24%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021
OPERATING ACTIVITIES
Net Income -$5.619M -$7.057M -$29.20M
YoY Change -43.97% -47.34% -34.87%
Depreciation, Depletion And Amortization $370.0K $562.0K $2.338M
YoY Change -36.75% 12.4% 25.09%
Cash From Operating Activities -$6.404M -$4.157M -$18.80M
YoY Change -32.0% -67.19% -56.95%
INVESTING ACTIVITIES
Capital Expenditures -$545.0K -$121.0K $497.0K
YoY Change -302.6% -81.09% -72.17%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $11.70M
YoY Change -100.0% -100.0% -199.98%
Cash From Investing Activities -$545.0K -$121.0K $11.20M
YoY Change -106.5% -101.43% -183.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.380M
YoY Change -70.8%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.41M 3.786M 3.742M
YoY Change 8575.83% -72.76% -75.71%
NET CHANGE
Cash From Operating Activities -6.404M -4.157M -18.80M
Cash From Investing Activities -545.0K -121.0K 11.20M
Cash From Financing Activities 10.41M 3.786M 3.742M
Net Change In Cash 3.462M -492.0K -3.868M
YoY Change -479.19% -105.07% -90.74%
FREE CASH FLOW
Cash From Operating Activities -$6.404M -$4.157M -$18.80M
Capital Expenditures -$545.0K -$121.0K $497.0K
Free Cash Flow -$5.859M -$4.036M -$19.30M
YoY Change -39.51% -66.45% -57.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
0
CY2020Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
703000
CY2019Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
0
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
143000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
391000
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001705843
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-38161
CY2021 dei Entity Registrant Name
EntityRegistrantName
Calyxt, Inc.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1967997
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
2800 Mount Ridge Road
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Roseville
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55113-1127
CY2021 dei City Area Code
CityAreaCode
651
CY2021 dei Local Phone Number
LocalPhoneNumber
683-2807
CY2021 dei Security12b Title
Security12bTitle
Common Stock ($(0.0001 par value)
CY2021 dei Trading Symbol
TradingSymbol
CLXT
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12213000
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
52658096000
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
42718930
CY2021 dei Auditor Firm
AuditorFirmId
42
CY2021 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2021 dei Auditor Location
AuditorLocation
Minneapolis, Minnesota
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13823000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17299000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
0
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
11698000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
499000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
393000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4887000
CY2021Q4 us-gaap Inventory Net
InventoryNet
0
CY2020Q4 us-gaap Inventory Net
InventoryNet
1383000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
859000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3930000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
15181000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
39590000
CY2021Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
99000
CY2020Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
597000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21731000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22860000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
183000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
280000
CY2021Q4 us-gaap Assets
Assets
37194000
CY2020Q4 us-gaap Assets
Assets
63327000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1260000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
929000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
339000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2891000
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2522000
CY2020Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1950000
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
172000
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
766000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
370000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
364000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
191000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
45000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4854000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6945000
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
17506000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
17876000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1518000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
702000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
113000
CY2021Q4 us-gaap Liabilities
Liabilities
23062000
CY2020Q4 us-gaap Liabilities
Liabilities
26452000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38874146
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38773994
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37165196
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37065044
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
211263000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
204807000
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
100152
CY2020Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
100152
CY2021Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1043000
CY2020Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1043000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-196092000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-166893000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
14132000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
36875000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37194000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
63327000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25987000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23851000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7296000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28557000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
35127000
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9280000
CY2021 us-gaap Gross Profit
GrossProfit
-2570000
CY2020 us-gaap Gross Profit
GrossProfit
-11276000
CY2019 us-gaap Gross Profit
GrossProfit
-1984000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11335000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11082000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15382000
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20537000
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
24138000
CY2021 clxt Management Fees
ManagementFees
45000
CY2020 clxt Management Fees
ManagementFees
252000
CY2019 clxt Management Fees
ManagementFees
1338000
CY2021 us-gaap Restructuring Costs
RestructuringCosts
0
CY2020 us-gaap Restructuring Costs
RestructuringCosts
685000
CY2019 us-gaap Restructuring Costs
RestructuringCosts
0
CY2021 us-gaap Operating Expenses
OperatingExpenses
26762000
CY2020 us-gaap Operating Expenses
OperatingExpenses
32556000
CY2019 us-gaap Operating Expenses
OperatingExpenses
37689000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-29332000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-43832000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-39673000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1528000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1414000
CY2020 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-878000
CY2019 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
110000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
19000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-126000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-49000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29199000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-44836000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39612000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-29199000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-44836000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-39612000
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.78
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.32
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.21
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37475763
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33882406
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32805684
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6001405
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5522418
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5606552
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
93397000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-39612000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9175000
CY2019 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
344000
CY2019 clxt Value Of Shares Withheld For Net Share Settlement
ValueOfSharesWithheldForNetShareSettlement
813000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
17000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
62508000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-44836000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4971000
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
212000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
14037000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-17000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
36875000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-29199000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2090000
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
227000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4139000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
14132000
CY2021 us-gaap Profit Loss
ProfitLoss
-29199000
CY2020 us-gaap Profit Loss
ProfitLoss
-44836000
CY2019 us-gaap Profit Loss
ProfitLoss
-39612000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1528000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2338000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1869000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1607000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
2090000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
4971000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
9175000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4887000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3765000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1122000
CY2021 clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
-594000
CY2020 clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
-211000
CY2019 clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
-882000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1383000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1211000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2594000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3331000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3122000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-493000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-360000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-148000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
259000
CY2021 clxt Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
-2542000
CY2020 clxt Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
347000
CY2019 clxt Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
537000
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
572000
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-231000
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
876000
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-811000
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-243000
CY2019 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
688000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18811000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43672000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31951000
CY2021 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-11698000
CY2020 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
11698000
CY2019 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
0
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
497000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1786000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2969000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11201000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13484000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2969000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4380000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15000000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
501000
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
963000
CY2019 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
CY2021 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0
CY2020 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
1518000
CY2019 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0
CY2021 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
364000
CY2020 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
360000
CY2019 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
275000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
227000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
212000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
344000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
813000
CY2021 clxt Proceeds From Sale And Lease Back Of Land Buildings And Equipment
ProceedsFromSaleAndLeaseBackOfLandBuildingsAndEquipment
0
CY2020 clxt Proceeds From Sale And Lease Back Of Land Buildings And Equipment
ProceedsFromSaleAndLeaseBackOfLandBuildingsAndEquipment
0
CY2019 clxt Proceeds From Sale And Lease Back Of Land Buildings And Equipment
ProceedsFromSaleAndLeaseBackOfLandBuildingsAndEquipment
414000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3742000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15407000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-330000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3868000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-41749000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-35250000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18289000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60038000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
95288000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14421000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18289000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60038000
CY2021 us-gaap Year Founded
YearFounded
2010
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Basis of Presentation and Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has prepared its Consolidated Financial Statements according to a</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ccounting principles generally accepted in the United States </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">and has included the accounts of Calyxt and its subsidiary.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires the Company to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes, including those related to revenue recognition, the net realizable value of inventories</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, stock-based compensation, and valuation allowances on deferred tax assets. Actual results could differ from those estimates.</span></p>
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4900000
CY2020Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
12165000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-29200000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18800000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14400000
CY2021Q4 clxt Finance Lease Obligations Fair Value Disclosure
FinanceLeaseObligationsFairValueDisclosure
14500000
CY2020Q4 clxt Finance Lease Obligations Fair Value Disclosure
FinanceLeaseObligationsFairValueDisclosure
15200000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000.0
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
800000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5508797
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2347665
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.15
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4621173
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.30
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
774959
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.20
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
61372
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.70
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
676335
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
10.75
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2789110
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.23
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4658425
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.47
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
227000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
212000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
344000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
344000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
179000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
905000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.010
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.042
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.010
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.007
CY2020 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.005
CY2019 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.016
CY2021 clxt Effective Income Tax Rate Reconciliation Officer Compensation
EffectiveIncomeTaxRateReconciliationOfficerCompensation
0.015
CY2020 clxt Effective Income Tax Rate Reconciliation Officer Compensation
EffectiveIncomeTaxRateReconciliationOfficerCompensation
-0.010
CY2019 clxt Effective Income Tax Rate Reconciliation Officer Compensation
EffectiveIncomeTaxRateReconciliationOfficerCompensation
-0.013
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.014
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.008
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.018
CY2021 clxt Effective Income Tax Rate Reconciliation Ppp Loan
EffectiveIncomeTaxRateReconciliationPppLoan
0.011
CY2020 clxt Effective Income Tax Rate Reconciliation Ppp Loan
EffectiveIncomeTaxRateReconciliationPppLoan
0
CY2019 clxt Effective Income Tax Rate Reconciliation Ppp Loan
EffectiveIncomeTaxRateReconciliationPppLoan
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.001
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.003
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.254
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.244
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.212
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
38671000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
33392000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
24852000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2724000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2531000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3637000
CY2021Q4 clxt Deferred Tax Assets Lease Obligations
DeferredTaxAssetsLeaseObligations
3820000
CY2020Q4 clxt Deferred Tax Assets Lease Obligations
DeferredTaxAssetsLeaseObligations
4574000
CY2019Q4 clxt Deferred Tax Assets Lease Obligations
DeferredTaxAssetsLeaseObligations
4640000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
3210000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2577000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2106000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
514000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
339000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
97000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
307000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
49082000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
44507000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
35639000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
45369000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
39898000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
30888000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
3713000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4609000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4751000
CY2021Q4 clxt Deferred Tax Liabilities Fixed Assets
DeferredTaxLiabilitiesFixedAssets
3667000
CY2020Q4 clxt Deferred Tax Liabilities Fixed Assets
DeferredTaxLiabilitiesFixedAssets
4609000
CY2019Q4 clxt Deferred Tax Liabilities Fixed Assets
DeferredTaxLiabilitiesFixedAssets
4746000
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
46000
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
0
CY2019Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
5000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3713000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
4609000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
4751000
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
228500000
CY2021Q4 clxt Operating Loss Carryforwards Not Expire
OperatingLossCarryforwardsNotExpire
131300000
CY2021Q4 clxt Operating Loss Carryforwards Subject To Expire
OperatingLossCarryforwardsSubjectToExpire
41900000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Lessee Finance Lease Term Of Contract1
LesseeFinanceLeaseTermOfContract1
P20Y
CY2021Q4 clxt Number Of Lease Extension Options
NumberOfLeaseExtensionOptions
4
CY2021Q4 us-gaap Lessee Finance Lease Renewal Term1
LesseeFinanceLeaseRenewalTerm1
P5Y
CY2017 us-gaap Sale And Leaseback Transaction Gain Loss Net
SaleAndLeasebackTransactionGainLossNet
7000000.0
CY2021 clxt Sale Leaseback Transaction Base Rent Interest Rate
SaleLeasebackTransactionBaseRentInterestRate
0.08
CY2021Q4 clxt Sale Leaseback Transaction Incremental Rent Percentage Annual
SaleLeasebackTransactionIncrementalRentPercentageAnnual
0.075
CY2021 clxt Sale Leaseback Transaction Annual Base Rent Payments
SaleLeasebackTransactionAnnualBaseRentPayments
1400000
CY2021 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
46000
CY2020 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
83000
CY2019 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
117000
CY2021 us-gaap Description Of Defined Contribution Pension And Other Postretirement Plans
DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans
The Company provides a 401(k) defined contribution plan for all regular full-time employees who have completed two months of service.
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
274000
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
309000
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
228000
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
0
CY2020Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
4317000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4887000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
0
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1383000
CY2021Q4 us-gaap Inventory Net
InventoryNet
0
CY2020Q4 us-gaap Inventory Net
InventoryNet
1383000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
29459000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
28406000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7728000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5546000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21731000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22860000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25987000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23851000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7296000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2090000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4971000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9175000
CY2021 us-gaap Interest Expense
InterestExpense
1431000
CY2020 us-gaap Interest Expense
InterestExpense
1435000
CY2019 us-gaap Interest Expense
InterestExpense
1490000
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
17000
CY2020 us-gaap Investment Income Net
InvestmentIncomeNet
557000
CY2019 us-gaap Investment Income Net
InvestmentIncomeNet
1600000
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1414000
CY2020 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-878000
CY2019 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
110000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13823000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17299000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58610000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
499000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
393000
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
388000
CY2021Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
99000
CY2020Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
597000
CY2019Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
1040000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14421000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18289000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60038000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
0
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
11698000
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
0
CY2021Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
14421000
CY2020Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
29987000
CY2019Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
60038000
CY2021 clxt Receivable From Jefferies For Shares Issued Under Atm Facility
ReceivableFromJefferiesForSharesIssuedUnderAtmFacility
260000
CY2021 us-gaap Interest Paid
InterestPaid
1425000
CY2020 us-gaap Interest Paid
InterestPaid
1455000
CY2019 us-gaap Interest Paid
InterestPaid
1472000
CY2021 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
691000
CY2020 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0
CY2019 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
414000

Files In Submission

Name View Source Status
0000950170-22-002808-index-headers.html Edgar Link pending
0000950170-22-002808-index.html Edgar Link pending
0000950170-22-002808.txt Edgar Link pending
0000950170-22-002808-xbrl.zip Edgar Link pending
clxt-20211231.htm Edgar Link pending
clxt-20211231.xsd Edgar Link pending
clxt-20211231_cal.xml Edgar Link unprocessable
clxt-20211231_def.xml Edgar Link unprocessable
clxt-20211231_htm.xml Edgar Link completed
clxt-20211231_lab.xml Edgar Link unprocessable
clxt-20211231_pre.xml Edgar Link unprocessable
clxt-ex10_39.htm Edgar Link pending
clxt-ex23_1.htm Edgar Link pending
clxt-ex31_1.htm Edgar Link pending
clxt-ex31_2.htm Edgar Link pending
clxt-ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img154352510_0.jpg Edgar Link pending
img90279524_0.jpg Edgar Link pending
img90279524_1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending